• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2401133 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2024-10-26 view
CXHL2300883 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2023-08-16 Guangzhou Repolarization Medical Technology Co Ltd view
CXHL2401132 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2024-10-26 view
CXHL2300882 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2023-08-16 Guangzhou Repolarization Medical Technology Co Ltd view
CXHL2401131 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2024-10-26 view
CXHB2200134 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) Supplementary Application 2022-08-23 Guangzhou Repolarization Medical Technology Co Ltd view
CXHL2300881 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2023-08-16 Guangzhou Repolarization Medical Technology Co Ltd view
CXHL2000595 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2020-11-24 广州再极医药科技有限公司 Guangzhou Repolarization Medical Technology Co Ltd In Review 2020-11-23 view
CXHL2000596 MAX-10181片 MAX-10181 Tablet Chemical Drugs(1) New Drug Application 2020-11-24 广州再极医药科技有限公司 Guangzhou Repolarization Medical Technology Co Ltd In Review 2020-11-23 view